Cancer Research Annual Meeting 2010  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 47, 4130-4133, August 1, 1987]
© 1987 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tuszynski, G. P.
Right arrow Articles by Gasic, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tuszynski, G. P.
Right arrow Articles by Gasic, G. J.

Thrombospondin, a Potentiator of Tumor Cell Metastasis1

George P. Tuszynski2, Tatiana B. Gasic, Vicki L. Rothman, Karen A. Knudsen and Gabriel J. Gasic

Lankenau Medical Research Center [G. P. T., K. A. K., V. L. R.], Philadelphia, Pennsylvania 19151, and Laboratory of Experimental Oncology, Pennsylvania Hospital [T. B. G., G. J. G.], Philadelphia, Pennsylvania 19107

The platelet-secreted protein thrombospondin (TSP) potentiates tumor cell metastasis. Human TSP injected i.v. into mice 5 min prior to i.v. injection of T241 sarcoma cells potentiates lung tumor colony formation. Several lines of evidence suggest that the TSP-enhancing effect involves both TSP-mediated tumor cell adhesion and the host's hemostatic system: (a) TSP potentiates the initial, rapid sequestering of tumor cells in the lung; (b) TSP promotes the adhesion of tumor cells in vitro; (c) the effect of TSP on tumor cell metastasis is dependent on the presence of platelets and a normal plasma clotting system, since TSP does not potentiate lung tumor colony formation in either thrombocytopenic mice or mice anticoagulated with Coumadin. Our results suggest a central role for TSP in the metastatic process.

1 This research was supported by Department of Health Services Grant CA33209; grants from the National Science Foundation (DCB-8409571) and the Muscular Dystrophy Association, Pennsylvania, an affiliate of the American Heart Association; Grant PDT-287 from the American Cancer Society; and the W. W. Smith Charitable Trust.

2 To whom requests for reprints should be addressed.

Received 1/14/87. Revised 4/ 7/87. Accepted 5/ 5/87.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Liu, P. Garg, S. Yang, P. Gong, M. A. Pallero, D. S. Annis, Y. Liu, A. Passaniti, D. Mann, D. F. Mosher, et al.
Epidermal Growth Factor-like Repeats of Thrombospondins Activate Phospholipase C{gamma} and Increase Epithelial Cell Migration through Indirect Epidermal Growth Factor Receptor Activation
J. Biol. Chem., March 6, 2009; 284(10): 6389 - 6402.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Ghoneim, M. Soula-Rothhut, C. Blanchevoye, L. Martiny, F. Antonicelli, and B. Rothhut
Activating Transcription Factor-1-mediated Hepatocyte Growth Factor-induced Down-regulation of Thrombospondin-1 Expression Leads to Thyroid Cancer Cell Invasion
J. Biol. Chem., May 25, 2007; 282(21): 15490 - 15497.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
O. Straume and L. A. Akslen
Expresson of Vascular Endothelial Growth Factor, Its Receptors (FLT-1, KDR) and TSP-1 Related to Microvessel Density and Patient Outcome in Vertical Growth Phase Melanomas
Am. J. Pathol., July 1, 2001; 159(1): 223 - 235.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. Tenan, G. Fulci, M. Albertoni, A.-C. Diserens, M.-F. Hamou, M. El Atifi-Borel, J.-J. Feige, M. S. Pepper, and E. G. Van Meir
Thrombospondin-1 Is Downregulated by Anoxia and Suppresses Tumorigenicity of Human Glioblastoma Cells
J. Exp. Med., May 15, 2000; 191(10): 1789 - 1798.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Sipes, H. C. Krutzsch, J. Lawler, and D. D. Roberts
Cooperation between Thrombospondin-1 Type 1 Repeat Peptides and alpha vbeta 3 Integrin Ligands to Promote Melanoma Cell Spreading and Focal Adhesion Kinase Phosphorylation
J. Biol. Chem., August 6, 1999; 274(32): 22755 - 22762.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Fontanini, L. Boldrini, A. Calcinai, S. Chine, M. Lucchi, A. Mussi, C. A. Angeletti, F. Basolo, and G. Bevilacqua
Thrombospondins I and II Messenger RNA Expression in Lung Carcinoma: Relationship with p53 Alterations, Angiogenic Growth Factors, and Vascular Density
Clin. Cancer Res., January 1, 1999; 5(1): 155 - 161.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
O. V. Volpert, J. Lawler, and N. P. Bouck
A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1
PNAS, May 26, 1998; 95(11): 6343 - 6348.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J. Adams and J Lawler
Diverse mechanisms for cell attachment to platelet thrombospondin
J. Cell Sci., January 4, 1993; 104(4): 1061 - 1071.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1987 by the American Association for Cancer Research.